Enterococcal septicemia in patients with hematological malignancies

  • M. Venditti
  • A. Tarasi
  • U. Visco Comandini
  • G. Gentile
  • C. Girmenia
  • A. Micozzi
  • P. Martino


Thirty-six cases of enterococcal septicemia in patients with hematological malignancies were reviewed retrospectively and categorized according to their clinical significance using strict previously described definitions. Overall, most of the infected patients were males (77 %), had acute leukemia (64 %), had recently received cytotoxic drug therapy (86 %), were granulocytopenic at the onset of septicemia (77 %), and acquired the infection during hospitalization (77 %). The source of septicemia was unknown in 18 (50 %) patients, intestinal in 15 (42 %) and intravascular in three (8 %). Mortality was 19 % among 21 inpatients who had clinically significant septicemia and 30 % among patients with septicemia of uncertain clinical significance. The fatal outcome could be definitively attributed to enterococcal septicemia in only one of the nine inpatients who died. Clinically significant septicemia appeared somewhat more frequently to be polymicrobial (p=0.06), whereas septicemia of unknown significance presented more frequently as breakthrough septicemia (p=0.013). Unless associated with intravascular infection, enterococcal septicemia in patients with hematological malignancies seems to represent a marker of cytotoxic drug damage of the intestinal mucosa rather than a truly invasive infection.


Internal Medicine Leukemia Clinical Significance Drug Therapy Hematological Malignancy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Meunier F: Infections in patients with acute leukemia and lymphoma. In: Mandell GP, Douglas RG, Bennett GE (ed): Principles and practice of infectious diseases. Churchill Livingstone, New York, 1990, p. 2265–2278.Google Scholar
  2. 2.
    Pizzo PA: Empirical therapy and prevention of infection in the immunocompromised host. In: Mandell GP, Douglas RG, Bennett GE (ed): Principles and practice of infectious diseases. Churchill Livingstone, New York, 1990, p. 2303–2312.Google Scholar
  3. 3.
    GIMEMA Infection Program: Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. Annals of Internal Medicine 1991, 115: 7–12.Google Scholar
  4. 4.
    Young LS: Antimicrobial prophylaxis in the neutropenic host: lessons of the past and perspective for the future. European Journal of Clinical Microbiology & Infectious Diseases 1988, 7: 93–97.Google Scholar
  5. 5.
    Malone DA, Wagner RA, Myers JP, Watanakunakorn C: Enterococcal bacteremia in two large community teaching hospitals. American Journal of Medicine 1986, 81: 601–606.CrossRefPubMedGoogle Scholar
  6. 6.
    Maki DG, Agger WA: Enterococcal bacteremia: clinical features, the risk of endocarditis, and management. Medicine 1988, 67: 248–270.PubMedGoogle Scholar
  7. 7.
    Gullberg RM, Homann SR, Phair JP: Enterococcal bacteremia: analysis of 75 episodes. Reviews of Infectious Diseases 1989, 11: 74–85.PubMedGoogle Scholar
  8. 8.
    Hoge CW, Adams J, Buchanan B, Sears SD: Enterococcal bacteremia: to treat or not to treat, a reappraisal. Reviews of Infectious Diseases 1991, 13: 600–605.PubMedGoogle Scholar
  9. 9.
    Von Reyn CF, Levy BS, Arbeit RD, Gerard F, Crumpacker CS: Infective endocarditis: an analysis based on strict case definitions. Annals of Internal Medicine 1981, 94: 505–518.PubMedGoogle Scholar
  10. 10.
    Martino P, Micozzi A, Venditti M, Gentile G, Girmenia C, Raccah R, Santilli S, Alessandri N, Mandelli F: Catheter-related right-sided endocarditis in bone marrow transplant recipients. Reviews of Infectious Diseages 1990, 12: 250–257.Google Scholar
  11. 11.
    Press OW, Ramsey PG, Larson EB, Fefer A, Hickman RO: Hickman catheter infections in patients with malignancies. Medicine 1984, 63: 189–200.PubMedGoogle Scholar
  12. 12.
    Armitage P: Statistical methods in medical research. Blackwell, Oxford, 1971.Google Scholar
  13. 13.
    Maki DG, Weise CE, Sarafin HW: A semiquantitative culture method for identifying intravenous-catheter-related infection. New England Journal of Medicine 1977, 296: 1305–1309.PubMedGoogle Scholar
  14. 14.
    Facklam RR, Carey RB: Streptococci and aerococci. In: Lennette EH, Balows A, Hausler WJ, Shadomy HJ (ed): Manual of clinical microbiology. American Society for Microbiology, Washington, DC, 1985, p. 154–175.Google Scholar
  15. 15.
    Sahm D, Torres C: Effects of medium and inoculum variation on screening for high-level aminoglycoside resistance inEnterococcus faecalis. Journal of Clinical Microbiology 1988, 26: 250–256.PubMedGoogle Scholar
  16. 16.
    Nicastri E, Tarasi A, Visco Comandini U, Gelfusa V, Di Rosa R, Di Rosa E, Venditti M, Serra P: High-level aminoglycoside resistance among enterococci: evaluation of an agar screen susceptibility test. Journal of Chemotherapy 1992, 4: 9–11.PubMedGoogle Scholar
  17. 17.
    National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 2nd edition. Tentative standard M7-T2, NCCLS, Villanova, PA, 1988.Google Scholar
  18. 18.
    Murray B: The life and times of theEnterococcus. Clinical Microbiology Reviews 1990, 3: 46–65.PubMedGoogle Scholar
  19. 19.
    Bryan CS, Reynolds KL, Brown JJ: Mortality associated with enterococcal bacteremia. Surgery, Gynecology & Obstetrics 1985, 160: 557–561.Google Scholar
  20. 20.
    Garrison RN, Fry DE, Berberich S, Polk HC: Enterococcal bacteremia: clinical implications and determinants of death. Annals of Surgery 1985, 120: 43–47.Google Scholar
  21. 21.
    Barrall DT, Kenney PR, Slotman GJ, Burchard KW: Enterococcal bacteremia in surgical patients. Archives of Surgery 1985, 120: 57–63.PubMedGoogle Scholar
  22. 22.
    Boulanger JM, Ford-Jones EL, Matlow AG: Enterococcal bacteremia in a pediatric institution: a four-year review. Reviews of Infectious Disease 1991, 13: 847–856.Google Scholar
  23. 23.
    Huicke MM, Spiegel CA, Gilmore MS: Bacteremia caused by hemolytic, high-level gentamicin-resistantEnterococcus faecalis. Antimicrobial Agents and Chemotherapy 1991, 35: 1626–1634.PubMedGoogle Scholar
  24. 24.
    Zervos MJ, Kauffmann CA, Therasse PM, Bergman AG, Mikesell TS, Schaberg DR: Nosocomial infection by gentamicin-resistantStreptococcus faecalis: an epidemiologic study. Annals of Internal Medicine 1987, 106: 687–691.PubMedGoogle Scholar
  25. 25.
    Nachamkin I, Axelrod P, Talbot JH, Fisher SH, Wennersten CB, Moellering RC, MacGregor RR: Multiply high-level aminoglycoside-resistant enterococci isolated from patients in a university hospital. Journal of Clinical Microbiology 1988, 26: 1287–1291.PubMedGoogle Scholar
  26. 26.
    Watanakunakorn C: The prevalence of high-level aminoglycoside resistance among enterococci isolated from blood cultures during 1980–1988. Journal of Antimicrobial Chemotherapy 1989, 4: 63–68.Google Scholar
  27. 27.
    Sapico FL, Canawati HN, Ginuas VJ, Gilmore DS, Montgomeric JZ, Tuddenham WJ, Facklam RR: Enterococci highly resistant to penicillin and ampicillin: an emerging clinical problem? Journal of Clinical Microbiology 1989, 27: 2091–2095.PubMedGoogle Scholar
  28. 28.
    Bush LM, Calmon J, Cherney CL, Wendeler M, Pitsakis P, Poupard J, Levison ME, Johnson CC: High-level penicillin resistance among isolates of enterococci. Implications for treatment of enterococcal infections. Annals of Internal Medicine 1989, 110: 515–520.PubMedGoogle Scholar
  29. 29.
    Rhinehart E, Smith NE, Wennersten C, Gross E, Freeman J, Eliopoulos JM, Moellering RC, Goldmann D: Rapid dissemination of beta-lactamase-producing, aminoglycoside-resistantEnterococcus faecalis among patients and staff on an infant-toddler surgical ward. New England Journal of Medicine 1990, 232: 1814–1819.Google Scholar
  30. 30.
    Green M, Barbadora K, Michaels M: Recovery of vancomycin-resistant gram-positive cocci from pediatric liver transplant recipients. Journal of Clinical Microbiology 1991, 29: 2503–2506.PubMedGoogle Scholar

Copyright information

© Friedr. Vieweg & Sohn Verlagsgesellschaft mbH 1993

Authors and Affiliations

  • M. Venditti
    • 1
  • A. Tarasi
    • 1
  • U. Visco Comandini
    • 1
  • G. Gentile
    • 2
  • C. Girmenia
    • 2
  • A. Micozzi
    • 2
  • P. Martino
    • 2
  1. 1.Servizio Aggregato di Consulenze Infettivologiche, Patologia Medica IIUniversita' “La Sapienza”RomeItaly
  2. 2.Ematologia, Dipartimento di Biopatologia UmaraUniversita' “La Sapienza”RomeItaly

Personalised recommendations